New Real-World Data for Miach Orthopaedics’ BEAR® Implant Demonstrate Low Retear Rates and Clinically Meaningful Improvements Following ACL Restoration Miach Orthopaedics, Inc., developer of the BEAR® Implant for anterior cruciate ligament (ACL) restoration, announced publication of new two-year results from…
Transcripta Bio & Synfini Collaborate to Identify a Lead Candidate Against a Key Driver of Huntington’s Disease Progression in a Matter of Weeks Transcripta Bio, an AI-powered drug discovery company focused on neurological and neuromuscular disease, and Synfini, Inc., an…
Italfarmaco and VeriSIM Life Partner to Develop Novel HDAC-Targeting Therapeutics for Neuromuscular, Fibrotic, and Rare Diseases Italfarmaco S.p.A., a global pharmaceutical company with established expertise in histone deacetylase biology and therapeutic development, and VeriSIM Life, an AI-enabled drug discovery and…
AstraZeneca opens new global strategic R&D center in Kendall Square, Cambridge, Massachusetts AstraZeneca announced the opening of its newest global strategic research and development (R&D) center, in Kendall Square, Cambridge, Massachusetts. The new state-of-the-art facility builds on the Company’s existing…
Mitsui Chemicals Launches InnoCell™ P-Type High Oxygen-Permeable Culture Plates to Accelerate Organoid-Based Drug Discovery Mitsui Chemicals, Inc. has launched InnoCell™ P-Type, a new adherent cell culture plate in its InnoCell™ series of cell culture ware, as of October 1, 2026.…
NeuWire Medical Announces FDA IDE Approval for STROKE-REWIRE Pivotal Study in Chronic Ischemic Stroke NeuWire Medical announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational Device Exemption (IDE) application for STROKE-REWIRE, a pivotal study evaluating the…
Italfarmaco and JCR Pharmaceuticals Enter into Exclusive License Agreement for the Development and Potential Commercialization of Novel Investigational Therapy for Hunter Syndrome in the United States, Europe, and Latin America Italfarmaco S.p.A. and JCR Pharmaceuticals Co., Ltd. announced an exclusive…
Summit Therapeutics Announces Clinical Trial Collaboration with AstraZeneca and Daiichi Sankyo to Evaluate Ivonescimab in Combination with TROP2-Directed ADC Datroway Summit Therapeutics Inc. announced a clinical trial collaboration agreement with Daiichi Sankyo and AstraZeneca to evaluate ivonescimab, a novel, potential…
SOLVE FSHD Accelerates Development of SFH-4090, a Novel DUX4 Inhibitor for FSHD SOLVE FSHD announced new nonclinical data supporting SFH-4090 for the treatment of facioscapulohumeral muscular dystrophy (FSHD). The data were presented at the 31st Annual Congress of the World…
Beyond Cellular Models: Longevica Capitalizes on World’s Largest In Vivo Longevity Study to Form Star-Studded Advisory Board and Unlock Human Health-and-Lifespan Pipeline Longevica Therapeutics, a biotechnology company bridging the translation gap between empirical geroscience and human therapeutics, announced the formation…
TriLink BioTechnologies® Secures Additional China Patent for CleanCap® Technology, Adding Broad Composition-of-Matter Protection to Reinforce Its Global IP TriLink BioTechnologies, LLC a Maravai LifeSciences company and global provider of life science reagents and services, announced it has been granted a…
Vividion Announces Publication of Clinical Data for VVD-214 in Nature Medicine, Highlighting Potential in Colorectal Cancer Vividion Therapeutics, Inc. a clinical-stage biopharmaceutical company and a wholly owned and independently operated subsidiary of Bayer AG, today announced the publication of the…